UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia

Brain (London, England : 1878), 2018-06, Vol.141 (6), p.1840-1854

2018

Volltextzugriff (PDF)

First-in-human PET quantification study of cerebral α4β2 nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]Flubatine

NeuroImage (Orlando, Fla.), 2015-09, Vol.118, p.199-208

2015

Volltextzugriff (PDF)

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors

Molecules (Basel, Switzerland), 2016-09, Vol.21 (9), p.1164

2016

Volltextzugriff (PDF)

Current radiotracers to image neurodegenerative diseases

EJNMMI radiopharmacy and chemistry, 2019-07, Vol.4 (1), p.17-17, Article 17

2019

Volltextzugriff (PDF)

Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults

European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (9), p.1618-1625

2018

Volltextzugriff (PDF)

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders

Journal of Nuclear Medicine, 2022-06, Vol.63 (Suppl 1), p.33S-44S

2022

Volltextzugriff (PDF)

Availability of Central α4β2 Nicotinic Acetylcholine Receptors in Human Obesity

Brain sciences, 2022-12, Vol.12 (12), p.1648

2022

Volltextzugriff (PDF)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity

Brain sciences, 2022-10, Vol.12 (11), p.1437

2022

Volltextzugriff (PDF)

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine – A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)

Frontiers in pharmacology, 2019-06, Vol.10, p.534-534

2019

Volltextzugriff (PDF)

Test-retest measurements of dopamine D 1 -type receptors using simultaneous PET/MRI imaging

European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.1025

2017

Volltextzugriff (PDF)

Noradrenergic control of neurobehavior in human binge‐eating disorder and obesity (NOBEAD): A smartphone‐supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging

The International journal of eating disorders, 2024-01, Vol.57 (1), p.206-220

2024

Volltextzugriff (PDF)

Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.1025-1032

2017

Volltextzugriff (PDF)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.1103-1115

2021

Volltextzugriff (PDF)

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study

Translational psychiatry, 2019-11, Vol.9 (1), p.301-10, Article 301

2019

Volltextzugriff (PDF)

Central noradrenaline transporter availability in highly obese, non-depressed individuals

European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.1056-1064

2017

Volltextzugriff (PDF)

Altered serotonin transporter availability in patients with multiple sclerosis

European journal of nuclear medicine and molecular imaging, 2014-05, Vol.41 (5), p.827-835

2014

Volltextzugriff (PDF)

Simultaneous PET/Mri in Stroke: A Case Series

Journal of cerebral blood flow and metabolism, 2015-09, Vol.35 (9), p.1421-1425

2015

Volltextzugriff (PDF)

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity

Obesity surgery, 2021-11, Vol.31 (11), p.4868-4876

2021

Volltextzugriff (PDF)

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

European journal of nuclear medicine and molecular imaging, 2021-03, Vol.48 (3), p.731-746

2021

Volltextzugriff (PDF)

Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter

Journal of neurology, 2011, Vol.258 (1), p.19-26

2011

Volltextzugriff (PDF)

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls

European journal of nuclear medicine and molecular imaging, 2011-09, Vol.38 (9), p.1702-1714

2011

Volltextzugriff (PDF)

Impact of EEG-vigilance on brain glucose uptake measured with [ 18F]FDG and PET in patients with depressive episode or mild cognitive impairment

NeuroImage (Orlando, Fla.), 2011-05, Vol.56 (1), p.93-101

2011

Volltextzugriff (PDF)

Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls

Stress (Amsterdam, Netherlands), 2019-01, Vol.22 (1), p.93-102

2019

Volltextzugriff (PDF)

Monoamine transporter availability in Parkinson’s disease patients with or without depression

European journal of nuclear medicine and molecular imaging, 2009-03, Vol.36 (3), p.428-435

2009

Volltextzugriff (PDF)

Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study

European journal of nuclear medicine and molecular imaging, 2016-06, Vol.43 (6), p.1096-1104

2016

Volltextzugriff (PDF)

1 – 25 von 413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(359)
Mit Volltextzugriff
(347)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(381)
Deutsch
(18)
Französisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(265)
Life Sciences & Biomedicine
(200)
Humans
(146)
Female
(90)
Male
(89)
Adult
(56)
Middle Aged
(54)
Physical Sciences
(52)
Neurosciences & Neurology
(40)
Medicine
(38)
Aged
(37)
Medicine & Public Health
(33)
Neurosciences
(32)
Animals
(31)
Physics
(31)
Radiology, Nuclear Medicine & Medical Imaging
(31)
Technology
(31)
Magnetic Resonance Imaging
(29)
Clinical Neurology
(25)
Pediatrics
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia

First-in-human PET quantification study of cerebral α4β2 nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]Flubatine

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors

Current radiotracers to image neurodegenerative diseases

Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders

Availability of Central α4β2 Nicotinic Acetylcholine Receptors in Human Obesity

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine – A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)

Test-retest measurements of dopamine D 1 -type receptors using simultaneous PET/MRI imaging

Noradrenergic control of neurobehavior in human binge‐eating disorder and obesity (NOBEAD): A smartphone‐supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging

Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study

Central noradrenaline transporter availability in highly obese, non-depressed individuals

Altered serotonin transporter availability in patients with multiple sclerosis

Simultaneous PET/Mri in Stroke: A Case Series

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls

Impact of EEG-vigilance on brain glucose uptake measured with [ 18F]FDG and PET in patients with depressive episode or mild cognitive impairment

Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls

Monoamine transporter availability in Parkinson’s disease patients with or without depression

Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study

Suchergebnisse filtern